geneflux corporate profile dec 2012
TRANSCRIPT
-
8/11/2019 GENEFLUX Corporate Profile Dec 2012
1/30
http://www.geneflux.net.my
(ISO9001:2008 Certified Company)
(ISO17025:2005 Accreditated
(ISO13485:2003 Certified laboratory facility)
Frost & Sullivan Award -2010, for the Niche company in
Molecular Diagnostics in Asia Pacific Region
Frost & Sullivan Award -2012, for the Southeast Asia
Fastest Growing Company in Molecular Diagnosticsfor Infectious Disease
10/1/2014 1
-
8/11/2019 GENEFLUX Corporate Profile Dec 2012
2/30
Geneflux - background
Geneflux Biosciences Sdn. Bhd. is a privately held,research and technology driven biotechnology and
molecular diagnostics company specialized in the
manufacture of molecular diagnostic kits and providing
services to healthcare industry. Establishment: in the year 2007 in Malaysia and India
BioNexus Status Company Award: June 2008
Geneflux Diagnostics Sdn. Bhd. is a wholly ownedsubsidiary of Geneflux Biosciences, dedicated to provide
molecular diagnostic services in Malaysia.
Establishment: in the year 2009 in Malaysia
10/1/2014 2
-
8/11/2019 GENEFLUX Corporate Profile Dec 2012
3/30
Management Board of Directors
Ir.Balaguru Naidu, Director & CEO
Dr.Prashanth G.Bagali, Director & COO, SVP
Mr. Azlan bin Baharom, Director
Mr. Mohammad Abdul Samad, Director
Business & Organizational Leaders
Ir.Balaguru Naidu, CEO
Dr.Prashanth G.Bagali, COO & SVP-Sci. and Tech.
10/1/2014 3
-
8/11/2019 GENEFLUX Corporate Profile Dec 2012
4/30
Company data
Authorized capital: RM500,000.00 Issued capital: RM425,000.00
Company #: 769382-V; Registration: April 13, 2007
Registered address: 7-3 block ), Jalan Selingsing 3, TamanSri Kuching, 51200, Kuala Lumpur, Malaysia
Business address: G1&G2, Menara KLH, Bandar Puchong
Jaya, 47100 Puchong, Selangor DE, Malaysia
Telephone; +60-3-80701154; Fax: +60-3-80703654
Email: [email protected], [email protected]
10/1/2014 4
-
8/11/2019 GENEFLUX Corporate Profile Dec 2012
5/30
Certification & registrations
BioNexus Status Company Award: June 2008 Certification under Malaysian Biotechnology Corporation
Achievement under Technofund scheme Ministry of Science, Technology and
Innovation (MOSTI)project grant and Award
Frost & Sullivan Award -2010, for the Niche company in Molecular Diagnostics
in Asia Pacific Region
Frost & Sullivan Award -2012, for the Southeast Asia Fastest Growing
Company in Molecular Diagnostics for Infectious Disease
Certification of ISO9001:2008
Certificationof ISO13485:2003
Accreditation of ISO17025:2005
RCPA Quality Assurance Program, Australia
Institute of Medical Research (IMR) Internal Quality Assessment Scheme,
Malaysia
Registrations: MOF, MITI, MATRDE10/1/2014 5
-
8/11/2019 GENEFLUX Corporate Profile Dec 2012
6/30
Global Presence*Geneflux Biosciences Private Limited, Bangalore
*Geneflux Diagnostics Limited, London
*Geneflux Biodiagnostics LLC, Detroit (USA)
Total Staff: 19
Science & Technology division: 8
Admin, HR & Support Division: 5
Sales, Marketing and Customer Support: 2 Logistics and Operations Division: 4
* = independent companies10/1/2014 6
-
8/11/2019 GENEFLUX Corporate Profile Dec 2012
7/30
Science & Technology team Prashanth Bagali, PhD (Genetics), PhD (Biotech),PDF (NIH-
NIDDK, USA)
Geetha Subramaniam, PhD (Med.Microbiology)
Parimala, BS (Biomedicine)
Pathma, BS (Biomedicine) Ketan Kumar, BE (biotechnology)
Erwina [B.S (1styear ) in Biotechnology]
Nurfasha [B.S (1styear) in Biotechnology]
Lab. Assistants
Lab. Technicians
10/1/2014 7
-
8/11/2019 GENEFLUX Corporate Profile Dec 2012
8/30
SCIENCE & TECHNOLOGY
Molecular Diagnostics Services Research
Viruses Bacteria Technologies
PCR Technology
2D & 3D Gels
analysis
Protein
Profiling
Contract
Research
Product
Development
Training
PRODUCTS AND SERVICES
Product
validation
Microarray Projects
10/1/2014 8
-
8/11/2019 GENEFLUX Corporate Profile Dec 2012
9/30
Core Technologies
Nucleic acid (DNA and RNA) based tests
Polymerase chain reaction (PCR)
Real time reverse transcriptase PCR (RT-PCR)
Microbiology lab tests
ELISA based tests
Rapid Antigen Tests
10/1/2014 9
-
8/11/2019 GENEFLUX Corporate Profile Dec 2012
10/30
Core Business
1. Manufacturing of molecular diagnostic kits
2. Providing diagnostic services to private and public
hospitals, clinics and medical centres
Geneflux Diagnostics Sdn. Bhd. is the wholly owned
subsidiary of Geneflux Biosciences Sdn Bhd.
Directors / shareholders:1. Ir.Balaguru Naidu
2. Dr.Prashanth G.Bagali
10/1/2014 10
-
8/11/2019 GENEFLUX Corporate Profile Dec 2012
11/30
Diagnostics Laboratory ISO9001:2008 certified quality management system
ISO17025:2005 (accreditation for laboratory quality and proficiency )
ISO13485:2003 design, manufacturing and production of molecular
diagnostic test kits and providing diagnostic services
4000 sq.ft built-in area
Very well equipped to handle 1000 samples for PCR analysis everyday
Statutory and regulatory compliance to Biosafety and clinical waste
disposal Work bench capacity: simultaneously 14 persons can work
Total investment: 2.5 million ringgits (approx. US$750,000)
10/1/2014 11
-
8/11/2019 GENEFLUX Corporate Profile Dec 2012
12/30
Diagnostics Laboratory (contd) Highlights
1. Five room concept:
Sample processing room
Pre-PCR room
Post-PCR room
Lab bench room
Decontamination / instrument room: Ice maker, freezers,
MilliQ water purification system, incubators, wash area
10/1/2014 12
-
8/11/2019 GENEFLUX Corporate Profile Dec 2012
13/30
Diagnostics Laboratory (contd) Molecular biology equipments
1. PCR machines (Biorad, Eppendorf, Qiagen) : 2 conventional
PCR, 3 real time PCR
2. Class II biological safety cabinets: 2
3. Freezers / fridges (Sanyo, Toshiba, Hitachi, Haier): 5
4. MilliQ water purification system
5. Gel documentation (Alpha Imager): 1
6. Centrifugesminicentrifuges, high speed: 47. Concentrator, autoclave, Ice maker and incubators
8. Others: Thermomixer, electrophoresis units, PCR
workstations, ductless fume cabinet
10/1/2014 13
-
8/11/2019 GENEFLUX Corporate Profile Dec 2012
14/30
Collaborations - R & D Research collaborators:
1. University of Malaya (UM)
2. Universiti Putra Malaysia (UPM)
3. Universiti Kebangsaan Malaysia (UKM)
4. University Technology Petronas (UTP)
5. Universiti Sains Malaysia (USM)6. Malaysian Palm Oil Board (MPOB)
Patents / Innovation / Licenses:
4 Licenses
10/1/2014 14
-
8/11/2019 GENEFLUX Corporate Profile Dec 2012
15/30
Market Need and demand
10/1/2014 15
-
8/11/2019 GENEFLUX Corporate Profile Dec 2012
16/30
Business strategy1. Franchising
2. Scaling up of business operation
3. Acquisition4. Strategic Alliance
10/1/2014 16
-
8/11/2019 GENEFLUX Corporate Profile Dec 2012
17/30
Investment for business expansion1. Pathology Services
(a) PCR tests: New tests will be included to the existing list of PCR
tests
(b) Genetic tests: Existing list of tests. Dedicated team of Sales
executives for building awareness in other states outside KL and
Selangor.
(c) Microarray and Next generation based sequencing based
diagnostic tests(d) Business relationship with IMR, HKL, Sungai Buloh Hospital and
National Public Health to increase inflow of samples with a "unique
profit sharing strategy".
10/1/2014 17
-
8/11/2019 GENEFLUX Corporate Profile Dec 2012
18/30
Investment for business expansion (contd.)
2. Clinical Research Services
(a) CRO (Contract Research Outsourcing) to biotech and
pharmaceutical companies
(b) Analytical services customized to specific requirement
10/1/2014 18
-
8/11/2019 GENEFLUX Corporate Profile Dec 2012
19/30
Investment for business expansion (contd.)(3) Wellness Centre- based on the concept of predictive, preventive
and personalized medicine.
(a) Individual offerings: Examples are Age wise tests for wellness,Gender based test package, Smoker panels, Drug and alcohol rehab
tests,
(b) Corporate Offerings: Pre-employment packages, Annual health
checkups
(c) Occupational Health offerings
10/1/2014 19
-
8/11/2019 GENEFLUX Corporate Profile Dec 2012
20/30
Investment for business expansion (contd.)(4) Centre of Excellence (CoE) will participate in national and
international quality assurance programs and schemes; to become
National Reference Laboratory
(a) CoE for Microbiology
(b) CoE for Molecular Pathology
(c) CoE for Cancer in collaboration with Merck or Roche or
AstraZenaca or Sanofi Pharma to popularize Companion Diagnostics
10/1/2014 20
-
8/11/2019 GENEFLUX Corporate Profile Dec 2012
21/30
Investment for business expansion (contd.)(5) Research and Development
(a) Medical Biotechnology with specific focus on diabetes, cancer, CVD
and others
(b) Agricultural Biotechnology with specific focus on medicinal plants
(6) Dental pulp stem cell banking:
10/1/2014 21
-
8/11/2019 GENEFLUX Corporate Profile Dec 2012
22/30
Products & Services
Geneflux conventional PCR and RT-PCR based kits
1. MyDENKit, detection and serotyping of dengue
virus using SybrGreen probe based real time PCR2. Chikungunya detection kit (lab use only) using
conventional PCR
3. MuRSAFlux , identification of Methicillin
resistance staphylococcus aureus (lab use only)
4. FluFinder-detection of H1N1 virus (lab use only)
10/1/2014 22
-
8/11/2019 GENEFLUX Corporate Profile Dec 2012
23/30
10/1/2014 23
-
8/11/2019 GENEFLUX Corporate Profile Dec 2012
24/30
There is great market need and demand for PCR tests and
opportunity in both public and private sectors. Geneflux
has the technological expertise and right team to provide
solution within the best TAT (turn around time) and ataffordable price.
There is money to be made!!!!
10/1/2014 24
-
8/11/2019 GENEFLUX Corporate Profile Dec 2012
25/30
At your service
Thank You10/1/2014 25
-
8/11/2019 GENEFLUX Corporate Profile Dec 2012
26/30
1. Sample Receiving ROOM
-
8/11/2019 GENEFLUX Corporate Profile Dec 2012
27/30
-
8/11/2019 GENEFLUX Corporate Profile Dec 2012
28/30
2.Pre-PCR room
-
8/11/2019 GENEFLUX Corporate Profile Dec 2012
29/30
-
8/11/2019 GENEFLUX Corporate Profile Dec 2012
30/30
3.Post PCR room